Alkem Laboratories Gains 1.15%: 7 Key Factors Driving the Week’s Mixed Momentum
2026-11-21 14:01:59Key Events This Week 16 Nov: Downgrade to Sell amid technical and financial concerns 17 Nov: Technical momentum shifts amid mixed market signals 18 Nov: Bearish technical shift despite modest price gain 19 Nov: Sharp open interest surge in derivatives amid mixed signals 19 Nov: Upgrade to Hold as technicals improve 20 Nov: Stock closes at ₹5,168.65, up 0.46% on the day <div class="stat-item...
Read More
Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals
2026-11-19 15:01:07Alkem Laboratories Ltd (ALKEM) has witnessed a notable 15.8% surge in open interest in its derivatives segment, signalling increased market activity despite the stock’s recent underperformance. This rise in open interest, coupled with volume patterns and shifting market positioning, offers insights into investor sentiment and potential directional bets in the mid-cap pharmaceutical stock.
Read More
Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-11-19 08:04:55Alkem Laboratories Ltd has witnessed a subtle but notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a complex interplay of market forces amid a challenging pharmaceutical sector environment.
Read More
Alkem Laboratories Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals
2026-11-18 08:04:38Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Despite a modest day gain of 0.78%, the broader technical landscape suggests caution for investors as momentum oscillators and moving averages point towards weakening price strength.
Read More
Alkem Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-11-17 08:03:16Alkem Laboratories Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish trends. Despite a modest day gain of 0.59%, the stock’s technical landscape reveals a complex interplay of bearish and bullish signals across weekly and monthly timeframes, prompting a recent downgrade in its Mojo Grade from Hold to Sell.
Read More
Alkem Laboratories Downgraded to Sell Amid Technical and Financial Concerns
2026-11-16 08:35:38Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 13 Nov 2026. This revision reflects deteriorating technical indicators, flat recent financial performance, and subdued long-term growth prospects, despite some strengths in management efficiency and valuation metrics.
Read More
Alkem Laboratories Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-11-16 08:03:33Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s recent downgrade from a Hold to a Sell rating by MarketsMOJO reflects growing concerns over its price action and momentum metrics, as the stock underperforms relative to the broader market and its sector peers.
Read MoreAlkem Laboratories Declines 2.95% Amid Volatile Week and Heavy Put Option Activity
2026-11-14 13:02:18Key Events This Week Nov 09: Stock opens strong at Rs.5,400 (+2.56%) outperforming Sensex Nov 12: Heavy put option activity and sharp open interest surge amid price decline Nov 12: Q2 FY27 results show strong revenue growth but margin and tax pressures Nov 13: Stock closes week at Rs.5,110 (-4.22% on day), underperforming Sensex Week OpenRs.5,265.20 <div class="stat-ite...
Read More
Rs 5,200 Puts Draw 8,540 Contracts on Alkem Laboratories Ltd as Stock Dips Below Key Moving Averages
2026-11-12 15:00:08The stock of Alkem Laboratories Ltd has slipped 3.52% today, underperforming its sector and the broader market, while 8,540 put contracts at the Rs 5,200 strike traded heavily ahead of the 23 November expiry. This surge in put activity, combined with the stock’s recent price action, suggests a nuanced picture of hedging and cautious positioning rather than outright bearish conviction.
Read MoreUpdate On US FDA Inspection At CompanyS Manufacturing Facility Located At Amaliya Daman
19-Nov-2026 | Source : BSEPlease find attached herewith disclosure regarding update on US FDA inspection at Companys manufacturing facility located at Amaliya Daman
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
18-Nov-2026 | Source : BSEPlease find attached herewith Q2 H1FY2027 - Earnings Conference Call Transcript
Announcement under Regulation 30 (LODR)-Newspaper Publication
13-Nov-2026 | Source : BSEPlease find attached herewith intimation for a copy of newspaper publication.
Corporate Actions
No Upcoming Board Meetings
Alkem Laboratories Ltd has declared 500% dividend, ex-date: 07 Aug 26
No Splits history available
No Bonus history available
No Rights history available